Myeloma Institute for Research and Therapy
Home
What is Myeloma?
About the Institute
Referring or
Becoming a Patient
Our Doctors and Staff
  Our Doctor Team
  Our Nursing Team and Other Health Professionals
UAMS Our Support Services
News/Events/Press Releases
Scientific Publications/Research
About Little Rock & Arkansas
About UAMS
About The Winthrop P. Rockefeller Cancer Institute
Travel, Hotels, Directions & Maps, UAMS Dining
Other Sources of Myeloma Information
Contact Us
Make a Donation

Job Opportunities

Clinical Faculty

Elias Anaissie, M.D., Professor of Medicine
Vice Chair and Director of Supportive Care, Myeloma Institute

M.D.  University of Paris XII, Creteil Faculty of Medicine, Paris, France,
and St Joseph University Medical School, Beirut, Lebanon. 
Residency (internal medicine), American University of Beirut Medical Center. 
Fellowship (hematology/oncology), American University of Beirut Medical Center. 
Fellowship (infectious diseases), University of Texas M.D. Anderson Cancer Center. 
Associate Professor of Medicine, M.D. Anderson Cancer Center, Houston, Texas. 
Adjunct Associate Professor of Pathology at University of Texas Medical Branch at Galveston.
Special Interest:
Prevention and management of infections and other complications in cancer patients

Selected Publications::

T. Mahfouz, M.H. Miceli, F. Saghafifar, S. Stroud, L. Jones-Jackson, R. Walker, M.L. Grazziutti, G. Purnell, A. Fassas, G. Tricot, B. Barlogie, E. Anaissie 18F-Fluorodeoxyglucose Positron Emission Tomography Contributes to the Diagnosis and Management of Infections in Patients With Multiple Myeloma: A Study of 165 Infectious Episodes  JCO 7857-7863 Nov 1 2005

Talamo G. Angtuaco E. Walker RC. Dong L. Miceli MH. Zangari M. Tricot G. Barlogie B. Anaissie EJ. Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy. J of Clin Onc. 23(22):5217-23, 2005 Aug 1.

McConnell, SA, Gubbins, PO, Anaissie, EJ. Are Antimicrobial –Impregnated Catheters Effective? Replace The Water and Grab Your Wash Cloth, We Have A Baby To Wash.  Clin Infec Dis. 2004: 39. 1829-1833

Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients Bone Marrow Transplantation 37, 857-864(01 May 2006) M.H. Miceli, L. Dong, M.L. Grazziutti, A. Fassas, R. Thertulien, F. Van Rhee, B. Barlogie, E.J. Anaissie

Recovery from neutropenia can be predicted by the immature reticulocyte fraction severals days before neutrophil recovery in autologous stem cell transplant recipients.  M.L. Grazziutti, L. Dong, M.H. Miceli, M. cottler-Fox, S.G. Krishna, A. Fassas, F. Van Rhee, B.M. Barlogie, E.J. Anaissie, Bone Marrow Transplantation 37, 403-409 (01 Feb, 2006)

 

 

About Multiple Myeloma // About the Myeloma Institute // Becoming a Patient
Highlights of Our Myeloma Program  // Our Physician Team // Our Nursing Team
News/Events/Press Releases // Scientific Publications/Research
About Little Rock & Arkansas // About UAMS // About The Winthrop P. Rockefeller Cancer Institute
Travel/Directions/Maps // Contact Us // Make a Donation

Having problems with the site? E-mail the Webmaster.
Copyright 2002-2005, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences
Terms and Conditions of Use

The information on the Myeloma Institute web site is not intended as a substitute for professional medical attention. The information is intended only as an aid in understanding current medical knowledge. A physician should always be consulted for any health concern or medical condition. The Myeloma Institute web site provides links to other organizations as a service to our readers. The Myeloma Institute is not responsible for the information provided on other web sites.

Notice of Privacy Practices
Myeloma Institute for Research and Therapy University of Arkansas for Medical Sciences